Closing Bell Overtime: Nvidia hits all-time high 10/2/26

Charles Schwab’s Kevin Gordon breaks down whether the recent yield roadblock for stocks is beginning to clear. Former Council of Economic Advisers Chair Jason Furman weighs the latest jobs data and what it means for the Fed’s next move. Needham’s Laura Martin questions whether enthusiasm around Meta’s Muse has gone too far as investors weigh its early traction against rising capex, competition and monetization risk. CrowdStrike President Michael Sentonas looks back at a wild week for AI and what the latest developments mean for cybersecurity. Meantime, our Annika Kim Constantino examines the next big obesity drug opportunity beyond GLP-1s and the new hormone attracting attention across biotech.